查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1233106

2023-2030 年按服务（医学写作与出版、医学监测、医学科学联络、医学信息、其他）、按行业、按地区、细分趋势划分的医疗事务外包市场规模、份额、趋势分析报告

Medical Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service (Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons, Medical Information, Others), By Industry, By Region And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

医疗事务外包市场的增长和趋势

Grand View Research, Inc. 的最新报告预计，2023 年至 2030 年全球医疗事务外包市场规模将达到 46 亿美元，复合年增长率为 13.6%。

医学教育的转型和治疗罕见病的孤儿药的兴起是推动市场增长的主要因素。 製药公司正在寻求帮助，以系统地定位这些疗法在市场上的治疗效果。 2021 年，美国食品药品监督管理局 (FDA) 的药物评价与研究中心 (CDER) 批准了 50 种新分子实体，其中一半以上 (26) 是孤儿药。 预计在预测期内，越来越多的孤儿药批准将推动全球医疗事务外包市场。

报销方案的变化和价格压力预计将增加製药和医疗设备製造商采用成本削减措施的机会。 为此，印度和中国等国家有望推动医疗事务外包的离岸外包。 药企将医务服务外包，以获得高质量的文檔，控制研发成本，降低医务团队建设的投资成本。 此外，製药公司和医疗器械製造商将医疗事务外包，以划分业务活动和管理产品生命週期。

此外，合同研究组织 (CRO) 正在通过提供具有成本效益的解决方案并遵守卫生当局的要求来推动市场增长。 在生物/製药外包行业，由于 COVID-19 大流行，研发需求增加。 这种需求的增加，以及大流行的其他影响，例如对临床试验及其外包服务的需求增加，已导致一些 CRO 转移和调整其业务重心。 大流行正在推动製药行业发生积极变化，推动更多製药公司和监管机构使用新技术进行远程质量审核和测试。 此外，随着数字化的发展，需要与患者群体互动并在专业护理中发挥作用的临床试验将成为医疗事务职能不可或缺的一部分，这有望减轻大流行的影响。

医疗事务外包市场报告亮点

  • 医学写作与出版领域将在 2022 年引领市场，并在预测期内实现强劲增长，因为预计市场对向医疗保健专业人员和患者传达医学信息的书面内容的需求不断增长。
  • 由于许多製药公司和医疗设备製造商的存在，到 2022 年，北美将以 34.9% 的份额主导全球市场。
  • 此外，医疗事务服务的高成本已成为一个主要挑战，许多北美医疗设备製造商将功能外包给在该领域具有强大专业知识的离岸第三方供应商。我来到
  • 不过，由于 CRO 提供具有成本效益的服务，预计亚太地区在预测期内将以最快的复合年增长率增长。 亚太地区改进的监管框架和熟练劳动力的可用性也在推动市场增长。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 服务
    • 行业
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析（模型 1）
  • 次要信息列表
  • 主要信息列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场展望
  • 细分市场展望

第 3 章医疗事务外包市场：变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 辅助市场展望
  • 市场动态
    • 市场驱动因素分析
      • 增加临床试验的数量
      • CRO 提供具有成本效益的优质服务
      • 严格的监管场景
    • 市场製约因素分析
      • 无法聘请有经验的技术人员
    • 行业问题
      • 关係管理
    • COVID-19 的影响
  • 医疗事务外包市场分析工具
    • 波特的五力分析
    • PESTEL 分析
    • 对主要交易和战略联盟的分析
      • 併购
      • 协作
      • 产品发布

第 4 章医疗事务外包市场：服务细分分析

  • 医疗事务外包：市场份额分析，2022 年和 2030 年
  • 医学写作和出版
  • 医学监测
  • 医学科学联络员 (MSL)
  • 医疗信息
  • 其他

第 5 章医疗事务外包市场：行业细分分析

  • 医疗事务外包：市场份额分析，2022 年和 2030 年
  • 医药
  • 生物製药
  • 医疗设备
    • 治疗性医疗设备
    • 诊断医疗设备

第 6 章医疗事务外包市场：区域分析

  • 医疗事务外包：市场份额分析，2022 年和 2030 年
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第七章公司简介

  • 公司简介
  • ICON plc
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
  • IQVIA
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
  • THE MEDICAL AFFAIRS COMPANY
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
  • Syneos Health
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
  • Thermo Fischer Scientific Inc.（PPD）
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
  • Ashfield Healthcare
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
  • ZEINCRO Group
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
  • Wuxi AppTec
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
  • SGS SA
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
  • Indegene
    • 公司概况
    • 财务业绩
    • 服务基准
    • 战略举措
Product Code: GVR-3-68038-891-6

Medical Affairs Outsourcing Market Growth & Trends:

The global medical affairs outsourcing market size is expected to reach USD 4.6 billion registering a CAGR of 13.6% from 2023 to 2030 according to a new report by Grand View Research, Inc. Transformation in the medical education and the rising number of orphan therapies for treatment of rare diseases are some of the key factors propelling the market growth. The pharmaceutical companies are looking for assistance to systematically position the therapeutic outcomes of these therapies in the market. During the year 2021, the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) approved 50 new molecular entities, of which more than half (26) were orphan drugs. A growing number of orphan drug approvals is expected to drive the global market for medical affairs outsourcing over the forecast period.

Changes in the reimbursement scenario and pricing pressure are expected to increase the adoption of cost-saving measures by the pharmaceutical and medical device companies. This is anticipated to promote off-shoring of medical affairs outsourcing in countries like India and China. Pharmaceutical companies are outsourcing medical affairs services to get high-quality documents, control the R&D cost, and reduce investment costs required to train the medical affairs team. Furthermore, pharmaceutical and medical device companies are outsourcing their medical affairs services to diverge their business activities and manage product life cycles.

In addition, Contract Research Organizations (CROs) offer cost-efficient solutions and compliance with the health authority requirements, thereby propelling market growth. The bio/pharmaceutical outsourcing industry has seen a rise in R&D demand because of the COVID-19 pandemic. This increase in demand, as well as other impacts from the pandemic, such as rising demand for clinical trials and its outsourcing services, have caused some CROs to shift focus and adjust their operations. The pandemic has pushed more pharmaceutical companies and regulators to use new technologies for remote quality audits and inspections, thus driving positive changes in the pharma industry. Also, digitalization has for clinical trials that requires interactions with patient groups, and role in specialty care are expected to become integral to the medical affairs function and reduce the impact of pandemic.

Medical Affairs Outsourcing market Report Highlights:

  • The medical writing & publishing segment led the market in 2022 and is expected to witness significant growth over the forecast period, owing to the increasing need for marketable written content to convey medical information to healthcare professionals and patients.
  • North America dominated the global market with a share of 34.9% in 2022 owing to the presence of a large number of pharmaceutical and medical devices companies in the region.
  • Moreover, the high cost of medical affairs services is a major challenge, which has encouraged various medical device companies in North America to outsource functions to third-party vendors in off-shore locations with a high level of expertise in the domain.
  • However, Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period, owing to cost-efficient service offering by the CROs in the region. In addition, improved regulatory framework and availability of a skilled workforce in APAC boosts the market growth.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Services
    • 1.1.2 Industry
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Primary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1
    • 1.10.2 Objective - 2
    • 1.10.3 Objective - 3
    • 1.10.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Medical Affairs Outsourcing Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Increasing number of clinical trials
      • 3.2.1.2 Cost-effectiveness and high quality services offered by CROs
      • 3.2.1.3 Stringent regulatory scenario
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Inability to hire experienced technical staff
    • 3.2.3 Industry Challenges
      • 3.2.3.1 Managing relationships
    • 3.2.4 COVID-19 Impact
  • 3.3 Medical Affairs Outsourcing Market Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 PESTEL Analysis
    • 3.3.3 Major Deals & Strategic Alliances Analysis
      • 3.3.3.1 Mergers and Acquisitions
      • 3.3.3.2 Collaboration
      • 3.3.3.3 Product Launch

Chapter 4 Medical Affairs Outsourcing Market: Services Segment Analysis

  • 4.1 Medical Affairs Outsourcings: Market Share Analysis, 2022 & 2030
  • 4.2 Medical Writing & Publishing
    • 4.2.1 Medical writing & publishing market, 2018 - 2030 (USD Million)
  • 4.3 Medical Monitoring
    • 4.3.1 Medical monitoring market, 2018 - 2030 (USD Million)
  • 4.4 Medical Science Liaisons (MSLs)
    • 4.4.1 Medical science liaisons (MSLs) market, 2018 - 2030 (USD Million)
  • 4.5 Medical Information
    • 4.5.1 Medical information market, 2018 - 2030 (USD Million)
  • 4.6 Others
    • 4.6.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Medical Affairs Outsourcing Market: Industry Segment Analysis

  • 5.1 Medical Affairs Outsourcings: Market Share Analysis, 2022 & 2030
  • 5.2 Pharmaceutical
    • 5.2.1 Pharmaceutical market, 2018 - 2030 (USD Million)
  • 5.3 Biopharmaceutical
    • 5.3.1 Biopharmaceutical market, 2018 - 2030 (USD Million)
  • 5.4 Medical Devices
    • 5.4.1 Medical devices market, 2018 - 2030 (USD Million)
    • 5.4.2 Therapeutic Medical Devices
      • 5.4.2.1 Therapeutic medical devices market, 2018 - 2030 (USD Million)
    • 5.4.3 Diagnostic Medical Devices
      • 5.4.3.1 Diagnostic medical devices market, 2018 - 2030 (USD Million)

Chapter 6 Medical Affairs Outsourcing Market: Regional Analysis

  • 6.1 Medical Affairs Outsourcing: Market Share Analysis, 2022 & 2030
  • 6.2 North America
    • 6.2.1 North America medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada medical affairs outsourcing market, 2018 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.2 UK
      • 6.3.2.1 UK medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.4 France
      • 6.3.4.1 France medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.5 Italy
      • 6.3.5.1 Italy medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.6 Spain
      • 6.3.6.1 Spain medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.7 Sweden
      • 6.3.7.1 Sweden medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.8 Denmark
      • 6.3.8.1 Denmark medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.3.9 Norway
      • 6.3.9.1 Norway medical affairs outsourcing market, 2018 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 China medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.3 India
      • 6.4.3.1 India medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.4 Japan
      • 6.4.4.1 Japan medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.5 Australia
      • 6.4.5.1 Australia medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.6 South Korea
      • 6.4.6.1 South Korea medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.4.7 Thailand
      • 6.4.7.1 Thailand medical affairs outsourcing market, 2018 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.5.4 Argentina
      • 6.5.4.1 Argentina medical affairs outsourcing market, 2018 - 2030 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE medical affairs outsourcing market, 2018 - 2030 (USD Million)
    • 6.6.5 Kuwait
      • 6.6.5.1 Kuwait medical affairs outsourcing market, 2018 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Company Profiles
  • 7.2 ICON plc
    • 7.2.1 Company overview
    • 7.2.2 Financial performance
    • 7.2.3 Service benchmarking
    • 7.2.4 Strategic initiatives
  • 7.3 IQVIA
    • 7.3.1 Company overview
    • 7.3.2 Financial performance
    • 7.3.3 Service benchmarking
    • 7.3.4 Strategic initiatives
  • 7.4 THE MEDICAL AFFAIRS COMPANY
    • 7.4.1 Company overview
    • 7.4.2 Financial performance
    • 7.4.3 Service benchmarking
    • 7.4.4 Strategic initiatives
  • 7.5 Syneos Health
    • 7.5.1 Company overview
    • 7.5.2 Financial performance
    • 7.5.3 Service benchmarking
    • 7.5.4 Strategic initiatives
  • 7.6 Thermo Fischer Scientific Inc. (PPD)
    • 7.6.1 Company overview
    • 7.6.2 Financial performance
    • 7.6.3 Service benchmarking
    • 7.6.4 Strategic initiatives
  • 7.7 Ashfield Healthcare
    • 7.7.1 Company overview
    • 7.7.2 Financial performance
    • 7.7.3 Service benchmarking
    • 7.7.4 Strategic initiatives
  • 7.8 ZEINCRO Group
    • 7.8.1 Company overview
    • 7.8.2 Financial performance
    • 7.8.3 Service benchmarking
    • 7.8.4 Strategic initiatives
  • 7.9 Wuxi AppTec
    • 7.9.1 Company overview
    • 7.9.2 Financial performance
    • 7.9.3 Service benchmarking
    • 7.9.4 Strategic initiatives
  • 7.10 SGS SA
    • 7.10.1 Company overview
    • 7.10.2 Financial performance
    • 7.10.3 Service benchmarking
    • 7.10.4 Strategic initiatives
  • 7.11 Indegene
    • 7.11.1 Company overview
    • 7.11.2 Financial Performance
    • 7.11.3 Service benchmarking
    • 7.11.4 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Mergers & Acquisitions
  • Table 4 Collaboration
  • Table 5 Product launch

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Medical affairs outsourcing market snapshot (2022)
  • Fig. 10 Medical affairs outsourcing market segmentation
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Medical affairs outsourcing market services outlook: Segment dashboard
  • Fig. 19 Medical affairs outsourcing market: Services movement analysis
  • Fig. 20 Medical writing & publishing market, 2018 - 2030 (USD Million)
  • Fig. 21 Medical monitoring market, 2018 - 2030 (USD Million)
  • Fig. 22 Medical science liaisons (MSLs) market, 2018 - 2030 (USD Million)
  • Fig. 23 Medical information market, 2018 - 2030 (USD Million)
  • Fig. 24 Others market, 2018 - 2030 (USD Million)
  • Fig. 25 Medical affairs outsourcing market industry outlook: Segment dashboard
  • Fig. 26 Medical affairs outsourcing market: Industry movement analysis
  • Fig. 27 Pharmaceutical market, 2018 - 2030 (USD Million)
  • Fig. 28 Biopharmaceutical market, 2018 - 2030 (USD Million)
  • Fig. 29 Medical devices market, 2018 - 2030 (USD Million)
  • Fig. 30 Therapeutic medical devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Diagnostic medical devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Regional market: Key takeaways
  • Fig. 33 Regional outlook, 2022 & 2030
  • Fig. 34 North America market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market, 2018 - 2030 (USD Million)
  • Fig. 38 UK market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market, 2018 - 2030 (USD Million)
  • Fig. 40 France market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 44 China market, 2018 - 2030 (USD Million)
  • Fig. 45 India market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 53 MEA market, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market, 2018 - 2030 (USD Million)